�������

As a psychiatrist at �����о��� Langone, I am dedicated to advancing the field of psychedelic-assisted therapy. My approach to patient care is deeply rooted in understanding psychiatric disorders through a multifaceted lens that includes biological, social, psychological, and psychospiritual dimensions. This comprehensive perspective guides my commitment to providing holistic care, ensuring that each individual’s unique experiences and needs are addressed.

I specialize in psychedelic-assisted therapy, focusing on conditions such as alcohol use disorder and major depressive disorder. My work in this area is driven by early data suggesting that these treatments can offer more holistic solutions to clinical concerns. At �����о��� Langone’s Center for Psychedelic Medicine (CPM), I am involved in various research studies, acting as a co-investigator, study therapist, and clinical supervisor. My goal is to integrate patients’ lived experiences into the therapeutic process, aiming to understand and ease their symptoms through innovative and emerging treatments.

Throughout my career, I have accumulated extensive experience in the practice of psychedelic therapy within the research setting. My work includes Phase 2 trials of psilocybin-assisted therapy and other psychedelic interventions for a variety of clinical indications. I am committed to fostering clinical and intellectual excellence in psychedelic psychiatry, both within the CPM and the broader community. My efforts are motivated by a desire to support patients and train the next generation of mental health professionals.

My journey into psychiatry was shaped by a diverse academic background and a passion for multidisciplinary inquiry. I began my undergraduate studies in the Great Books program at St. John’s College, exploring philosophy, literature, mathematics, science, and the arts. This eclectic foundation led me to pursue scientific research at the National Institute of Mental Health (NIMH) and later, an MD/PhD program at UCLA. After completing my PhD in neuroscience, I returned to medical school with a vision of integrating science, service, and the humanities. This vision ultimately led me to psychiatry and psychedelic research, where I strive to advance the rigor, ethics, and understanding of these treatments in service of patients, participants, and the public.